Elegen is blazing a path towards a biology-based economy with a highly innovative approach to DNA synthesis that delivers an industry leading length of 7kb in 7 business days with a 99.999% per base accuracy. Our multidisciplinary team of best-in-class biologists, chemists, hardware, and software engineers apply cutting-edge technologies and methods to solve critical bottlenecks in synthetic biology workflows to help our customers in pharma, biotech, agbio, and biomanufacturing streamline their work and realize the full potential of programmable biology.
We are seeking a Senior Software Development Engineer in Test to help develop and scale our enterprise software test infrastructure for commercial operation. You will partner with our internal and contract SQA team to provide white-box testing support. You will be responsible for building software automation and infrastructure for Back-End and Front-End testing and providing tooling for ensuring all products meet quality criteria and industry best practices. Responsibilities will include infrastructure automation, CICD platform support, test planning, execution, monitoring, analysis of all software applications. You will drive the development of our test specification, automation tooling and test infrastructure implementation, bug tracking/resolution, and overall quality.
This is a rare and exciting opportunity for a highly motivated team leader looking to join a uniquely innovative, rapidly moving, high impact start-up. In addition to taking on the challenges of managing our production team, you will help us establish a strong culture of mutual respect, integrity, and collaboration while working alongside some of Silicon Valley’s best scientists and engineers, and professionals.
Core Responsibilities:
- Develop and maintain FE automation framework using Cypress or Selenium
- Design, develop, execute BE automation functional regression in security testing, and performance/load/stress testing.
- Create test strategy, test plans, and execution plans for manual/ad-hoc/automation for both FE and BE
- Contribute to the Full Stack SDLC process including technical requirements, analysis, design, development, testing, defect fixes, and software support.
- Assist in translating business requirements into RDBMS entity modeling and physical design.
- Utilize source control and build management tools like GitHub for version control.
- Participate in Agile development practices and support scrum processes using JIRA for backlog, tasks, and defect management.
- Participate in UX and website design for customer-facing portals and services.
- Contribute to the design and implementation of REST APIs, Microservices, and Service mesh architecture using domain-driven design on AWS, leveraging API Gateway and Lambda.
Essential Qualifications &Experience:
- Proficiency in communication and teamwork.
- Minimum of 5 years of hands-on experience in developing test plans, test tools, and test frameworks.
- Experience in both manual and automation testing.
- Strong automation experience in Selenium, Cypress, and Postman
- Strong knowledge of REST API design using Web Services on AWS
- Basic familiarity with databases, web servers, and UI/UX design.
- Knowledge of front-end languages, libraries, and JavaScript frameworks.
Preferred Qualifications & Experience:
- Interest in synthetic biology, DNA synthesis, or Life Science Tools.
- Background in biotech or molecular diagnostics is a plus.
- Exposure to authentication methods and security practices.
Salary and Benefits:
The annual base salary compensation for this role, if based in California, is: $140,000 - $165,000. Compensation may be different in other locations. Final compensation also includes bonus, equity and benefits. Specific offer packages are determined by multiple factors, including candidate skill, experience, expertise, and location.
✓ Healthcare ✓ Dental ✓ Vision ✓ Learning Allowance
✓ 401K ✓ Flexible PTO ✓ Short Term Disability ✓ Fitness Allowance
About The Company:
Founded and led by Dr. Matthew Hill and located in San Carlos, CA, Elegen is well-capitalized by top life science investors, including Andreessen Horowitz, 8VC, and KdT. The company is advised and staffed by leading biotechnology scientists and entrepreneurs, including Dr. Marc Unger, inventor of the Nanoflex™ valve, and former CSO of Fluidigm. Dr. Hill has a PhD from Stanford and a proven track record of advancing innovative technologies from invention to commercial success. Over eight years in his previous role as VP of R&D at a leading molecular diagnostics company, he co-invented and launched five precision molecular diagnostic products, including a best-in-class noninvasive prenatal test used by millions. These products earn more than $350 million per year in revenue and enabled an IPO.
Elegen is an Equal Opportunity Employer.
Elegen provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, genetic characteristics, or any other category protected by law. All applicants have rights under the following Federal Employment Laws:
- Family and Medical Leave Act (FMLA)
- Equal Employment Opportunity (EEO)
- Employee Polygraph Protection Act (EPPA)
What We Do
We are now at the dawn of the synthetic biology revolution, which will spawn new applications, markets, and business models, improving human lives in countless ways. This revolution will be driven by new technologies that enable DNA writing at speed and scale.
To catalyze this revolution, Elegen is creating a suite of ground-breaking technologies to achieve DNA writing with unparalleled speed, cost, and quality. Elegen is unlocking the power to reprogram biology and create biologic solutions in order to solve some of humanity’s greatest challenges.
Founded and led by Dr. Matthew Hill and located in San Carlos, CA, Elegen is a stealth-mode company that is well capitalized by top life science investors, including Andreessen Horowitz, 8VC, and KdT. The company is advised and staffed by leading biotechnology scientists and entrepreneurs, including Dr. Marc Unger, inventor of the Nanoflex™ valve and former CSO of Fluidigm. Dr. Hill has a PhD from Stanford and a proven track record of advancing innovative technologies from invention to commercial success.
